Progression in ALS is not linear but is curvilinear

Area of Science:

• Neurology
• Clinical Medicine
• Biostatistics

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
• Understanding the ALS progression curve and its influencing factors is crucial for patient management and therapeutic development.

Purpose of the Study:

• To determine the non-linear progression curve of ALS.
• To assess the impact of clinical variables on the rate of ALS progression.
• To evaluate the association between functional decline and survival in ALS patients.

Main Methods:

• Prospective data collection from 1,884 ALS patients (2002-2008).
• Analysis of demographic data, ALS Functional Rating Scale-Revised (ALSFRS-R), Manual Muscle Testing (MMT), and survival.
• Utilized generalized additive mixed models, linear mixed effects models, and Cox proportional hazards models.

Main Results:

• ALSFRS-R and MMT scores exhibited a curvilinear decline, best described by a quadratic fit.
• Older age at onset, bulbar onset, and more severe bulbar features were associated with faster decline.
• Higher rates of decline in ALSFRS-R and MMT, older age at onset, and bulbar onset predicted shorter survival.

Conclusions:

• ALS progression is non-linear, with accelerated decline in early and late disease phases.
• Age at onset and bulbar involvement significantly influence ALS progression rate and survival.
• The rate of functional decline, particularly early on, is a critical predictor of survival in ALS.